Catatonia Associated with Initiating Paliperidone Treatment

We present a case of catatonia, which occurred shortly after starting a new antipsychotic, paliperidone, an active metabolite of risperidone. Catatonia may be caused by a variety of conditions, including metabolic, neurologic, psychiatric and toxic processes. Interestingly, risperidone, which has be...

Descripción completa

Detalles Bibliográficos
Autores principales: McKeown, Nathanael J., Bryan, James H., Horowitz, B Zane
Formato: Texto
Lenguaje:English
Publicado: Department of Emergency Medicine, University of California, Irvine School of Medicine 2010
Materias:
Neurobehavioral
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2908655/
https://www.ncbi.nlm.nih.gov/pubmed/20823970
Descripción
Sumario:We present a case of catatonia, which occurred shortly after starting a new antipsychotic, paliperidone, an active metabolite of risperidone. Catatonia may be caused by a variety of conditions, including metabolic, neurologic, psychiatric and toxic processes. Interestingly, risperidone, which has been thought to cause several cases of catatonia, has also been recommended as a potential treatment. We discuss potential mechanisms for causes of drug-induced catatonia as well as potential treatment options.

Ejemplares similares